EP Patent

EP3028707A1 — Methods for treating or preventing ophthalmological diseases

Assigned to Iveric Bio Inc · Expires 2016-06-08 · 10y expired

What this patent protects

This invention relates to methods and compositions useful for the treatment or prevention of an ophthalmological disease, comprising administration of an effective amount of a PDGF antagonist and a VEGF antagonist to a mammal in need thereof.

USPTO Abstract

This invention relates to methods and compositions useful for the treatment or prevention of an ophthalmological disease, comprising administration of an effective amount of a PDGF antagonist and a VEGF antagonist to a mammal in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3028707A1
Jurisdiction
EP
Classification
Expires
2016-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Iveric Bio Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.